Press Releases.

Month Year

Month Year

Investor Alerts

November 02, 2020

Regulus Therapeutics Announces Achievement of Interim Enrollment Milestone Under Collaboration with Sanofi

Regulus to Receive Remaining $5 Million Payment for Enrollment Milestone
October 15, 2020

Regulus Therapeutics Announces First Patient Dosed in Phase 1b Clinical Trial of RGLS4326 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
October 13, 2020

Regulus Therapeutics Announces Receipt of $5 Million Milestone and Material Payments from Sanofi

Proceeds Used to Repay Debt Principal with Oxford Finance
September 11, 2020

Regulus Therapeutics to Present at the H.C. Wainwright 22nd Annual Virtual Global Investment Conference
September 03, 2020

Regulus Therapeutics to Present at the 2020 Wells Fargo Virtual Healthcare Conference

Show per page